Upcoming Allied Market Research
Controlled Substance Market

Controlled Substance Market

- Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A08196
Pages: NA
Mar 2023 | 1232 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Controlled Substance Market

Request Now !

One of the biggest challenge faced by prescriber of drugs is that every individual requires different levels of tolerance and variable opioid doses to obtain adequate pain relief. Controlled substances are medications or illicit drugs which are active in the central nervous system and can potentially cause a relative physical and mental dependence which can lead to addiction of those drugs. Furthermore, these substances can have harmful effects and health consequences when consumed high doses. These drugs have extensive implications on filling and refilling of these substances. In 1970, five specific 'Schedules' describing abuse potential, with Schedule 1 having the highest potential for abuse and each schedule thereby after that with low abuse potential were established under Controlled Substances Act. Manufacturers and dispensaries of these drugs, require a prior registration with the Drug Enforcement Agency (DEA), the organization responsible for regulating controlled substances at the federal level. Controlled substances consists of drugs like opioids, depressants, stimulants, anabolic steroids and hallucinogens. Controlled substances such as morphine, Ritalin and Valium are available only via prescription.


COVID – 19 scenario analysis:  

  • The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
  • Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
  • Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
  • Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
  • Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to chondroitin sulfate has been reduced and this segment have to face negligence subsequently causing negative impact on controlled substances market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Growing number of prescription medicine, rising preference of physicians for prescribing controlled substances  as they offer high-therapeutic efficacy, better patient response and reduced treatment cost over the conventional drug delivery systems are expected to boost the growth. Due to highly competitive market, the pharmaceutical firms actively keep experimenting as per industry needs and fund the R&D activities to innovate solutions and better drug delivery systems would fuel the market growth. Heavy funding to R&D activities by key market players for developing highly efficient treatments and therapies for chronic such as cancer, diabetes, and hypertension is expected to surge the demand in the market for controlled substances. For example, TAR-200 (Gemcitabine) used in treatment of bladder cancer includes a controlled release drug delivery system which is a product by biomedical company Taris. 

Increasing incidences of diseases, rising geriatric population globally is among key factors contributing to the market growth. Various parameters like physical, mental and biological functions affects the medicine intake of geriatric population and also their body isn’t acquainted to withstand high doses and extreme side-effects of drugs. Hence, these challenges would create demand for controlled substances with rising number of patients. 

In comparison with the conventional delivery systems, the controlled substances are capable of imposing therapeutic effect for longer duration, target-specific drug delivery ensuring efficacy along with reduction in dose strength and dosage frequency, enhance patient response to the drug and achieve uniform drug effect. Thus, with variety of advantages and attributes possessed by controlled substances, their acceptance is expected to increase at a significant rate.

However, stringent guideline imposed by Drug Enforcement Agency (DEA) and the suspicious order monitoring (SOM) requirement that is a mandate foe registered distributors of opioids is regulated by DEA to keep check on suspicious drugs, lack of awareness of controlled substance and high prevalence of illegal controlled substances are restrains that might hamper the growth of controlled substances market. 

Pain management segment to increases use of opioids in advanced cancer treatment

Pain management segment is a prominent segment for cancer patients as opioids are used to relieve subjects suffering from cancer and reduce the discomfort caused due to pain syndromes. The increase in prescription of opioids for its utilization in cancer treatment is a major reason guiding the market growth for pain management segment. However, opioids have some side effects leading to restrain its adoption amongst advanced cancer patients. Consumption of opioids can cause certain side effects on health such as cognitive impairment and delirium. Pharmaceutical organizations are taking various initiatives to overcome these drawbacks. Educating doctors and healthcare providers about complex nature of pain management and awareness about screening in the early stages of delirium is being spread as a part of action plan in order minimize side effects. Mini Mental State Examination and the Memorial Delirium-Assessment Scale tools are used to evaluate the severity of side effects such as cognitive impairment and delirium in patients. Thus, these efforts taken in maximizing usage of opioids and reducing their side effects parallelly will lead to enormous growth of pain management segment.

North America region to dominate the market 

North America to dominate the controlled substances market. The dominance is due to factors like rise in the number of hospitals as well as patient pools due to rising burden of chronic diseases such as CVD, cancer and diabetes, growing investment in R&D activities, favoring policies by government for development on controlled drug release systems, high strain to achieve better health outputs at lower costs, and presence of leading industry players in the region is promoting adoption of the product are propelling the growth of controlled substances market in the region.

Key benefits of the report:

  • This study presents the analytical depiction of the global controlled substance industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global controlled substance market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global controlled substance market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global controlled substance market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Controlled Substance Market research report:

  • Who are the leading market players active in the controlled substance market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the controlled substance market?
  • What are the projections for the future that will help in taking further strategic steps?

Controlled Substance Market Report Highlights

Aspects Details
By Product
  • Opioids
  • Stimulants
  • Depressants
  • Cannabinoids
By Application
  • Pain management
  • Sleep disorders
  • Depression and anxiety
  • Seizure
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players GW Pharmaceuticals, Orbis Biosciences Inc., Merck and Co. Inc., Alkermes plc, Johnson and Johnson, Corium International Inc., Depomed Inc., Pfizer Inc, Aradigm Corporation, Capsugel

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Controlled Substance Market

Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers